Goldman Sachs: Maintains PTC Therapeutics (PTCT.US) rating, adjusted from sell to sell rating, and adjusted target price from $18.00 to $32.00.
高盛：维持PTC Therapeutics(PTCT.US)评级，由卖出调整至卖出评级, 目标价由18.00美元调整至32.00美元。
Goldman Sachs: Maintains PTC Therapeutics (PTCT.US) rating, adjusted from sell to sell rating, and adjusted target price from $18.00 to $32.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.